Drug
Nebivolol
Nebivolol: highest development phase Post-Market, developed by Menarini. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Menarini
Trials
| Drug | Phase | Indication |
|---|---|---|
| Nebivolol 5 mg NCT06104423 | Post-Market | Hypertension |
| Nebivolol NCT05513937 | Post-Market | Hypertension |
Latest
No recent events.
Follow Nebivolol on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.